Alawwal Invest recommends ‘hold’ on Dallah, raises TP to SAR 121

31/08/2015 Argaam

Alawwal Invest has recommended a “hold” rating on Dallah Healthcare Holding Co. and raised the stock’s target price to SAR 121 for a 12-month period, the brokerage firm said in a report.

 

The company, which operates medical facilities in Saudi Arabia, is expected to see a rise in its earnings per share amid growing demand for medical services, as well as its expansion plans, the report added.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.